|
| 37131792 | Transcriptome Complexity Disentangled: A Regulatory Molecules Approach. | bioRxiv | 2024 |
| 36715691 | Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration. | Cancer Discov | 2023 |
| 37023372 | Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia. | Blood | 2023 |
| 36216587 | Sequences of Events from the Electronic Medical Record and the Onset of Infection. | Chem Biodivers | 2022 |
| 36250792 | CEDA: integrating gene expression data with CRISPR-pooled screen data identifies essential genes with higher expression. | Bioinformatics | 2022 |
| 35966389 | <i>SITH:</i> An R package for visualizing and analyzing a spatial model of intratumor heterogeneity. | Comput Syst Oncol | 2022 |
| 34601554 | RCytoGPS: an R package for reading and visualizing cytogenetics data. | Bioinformatics | 2021 |
| 33515233 | Mercator: a pipeline for multi-method, unsupervised visualization and distance generation. | Bioinformatics | 2021 |
| 33648439 | Pattern recognition in lymphoid malignancies using CytoGPS and Mercator. | BMC Bioinformatics | 2021 |
| 33707228 | DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. | Genome Res | 2021 |
| 33862229 | Simulation-derived best practices for clustering clinical data. | J Biomed Inform | 2021 |
| 33750375 | A novel model to label delirium in an intensive care unit from clinician actions. | BMC Med Inform Decis Mak | 2021 |
| 32483590 | Unsupervised machine learning and prognostic factors of survival in chronic lymphocytic leukemia. | J Am Med Inform Assoc | 2020 |
| 31794247 | Explaining Gene Expression Using Twenty-One MicroRNAs. | J Comput Biol | 2020 |
| 33059160 | CytoGPS: A large-scale karyotype analysis of CML data. | Cancer Genet | 2020 |
| 33110146 | Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model. | Sci Rep | 2020 |
| 32554930 | LC-FACSeq is a method for detecting rare clones in leukemia. | JCI Insight | 2020 |
| 30408569 | Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC. | J Thorac Oncol | 2019 |
| 31861985 | A protocol to evaluate RNA sequencing normalization methods. | BMC Bioinformatics | 2019 |
| 31582354 | Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. | Lancet Oncol | 2019 |
| 31292113 | Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. | Blood | 2019 |
| 31263896 | CytoGPS: a web-enabled karyotype analysis tool for cytogenetics. | Bioinformatics | 2019 |
| 31105032 | LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML. | EBioMedicine | 2019 |
| 31161200 | Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing. | Bioinformatics | 2019 |
| 30563911 | Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. | Genome Res | 2019 |
| 30689715 | Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing. | Bioinformatics | 2019 |
| 29310570 | Thresher: determining the number of clusters while removing outliers. | BMC Bioinformatics | 2018 |
| 30017829 | Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma. | J Thorac Oncol | 2018 |
| 29881252 | Decomposing the Apoptosis Pathway Into Biologically Interpretable Principal Components. | Cancer Inform | 2018 |
| 29976738 | Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways. | Haematologica | 2018 |
| 30305013 | Thirty biologically interpretable clusters of transcription factors distinguish cancer type. | BMC Genomics | 2018 |
| 29681454 | Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. | Cell | 2018 |
| 29624814 | eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer. | Cancer Sci | 2018 |
| 29506475 | IntLIM: integration using linear models of metabolomics and gene expression data. | BMC Bioinformatics | 2018 |
| 29505696 | Histone Modification Patterns Using RPPA-Based Profiling Predict Outcome in Acute Myeloid Leukemia Patients. | Proteomics | 2018 |
| 27573556 | Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target. | Leukemia | 2017 |
| 28412730 | The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia. | Oncotarget | 2017 |
| 28165654 | Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. | Cancer Sci | 2017 |
| 28270436 | Focal Adhesion Kinase as a Potential Target in AML and MDS. | Mol Cancer Ther | 2017 |
| 28185526 | Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia. | Leuk Lymphoma | 2017 |
| 29560090 | Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention. | Oncotarget | 2017 |
| 28538184 | Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors. | Cell Rep | 2017 |
| 27885271 | p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status. | Leukemia | 2017 |
| 27542854 | Genetic variants in thyroid cancer distant metastases. | Endocr Relat Cancer | 2016 |
| 26420858 | A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition. | Clin Cancer Res | 2016 |
| 26256940 | Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT). | Biol Blood Marrow Transplant | 2016 |
| 27663479 | Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer. | Semin Oncol | 2016 |
| 27480147 | The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer. | J Clin Oncol | 2016 |
| 27199546 | Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream Analysis. | Cancer Inform | 2016 |
| 27533304 | Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer Patients. | J Clin Endocrinol Metab | 2016 |